AddLife AB (publ) (STO: ALIF.B)

Market Cap	19.86B
Revenue (ttm)	9.99B
Net Income (ttm)	118.00M
Shares Out	121.86M
EPS (ttm)	0.97
PE Ratio	168.33
Forward PE	34.81
Dividend	0.50 (0.31%)
Ex-Dividend Date	May 10, 2024

Volume	227,295
Open	160.00
Previous Close	159.90
Day's Range	159.00 - 163.50
52-Week Range	54.75 - 163.50
Beta	1.22
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 23, 2024

About AddLife AB

AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1906
• Employees: 2,301
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ALIF.B

Financial Performance

In 2023, AddLife AB's revenue was 9.69 billion, an increase of 6.62% compared to the previous year's 9.08 billion. Earnings were 190.00 million, a decrease of -60.42%.